Compare · TMO vs XONE
TMO vs XONE
Side-by-side comparison of Thermo Fisher Scientific Inc (TMO) and The ExOne Company (XONE): market cap, price performance, sector, and recent activity on the wire.
Summary
- TMO operates in Industrials, while XONE operates in Capital Goods - the two are in different parts of the market.
- TMO is the larger of the two at $174.52B, about 292.3x XONE ($597.0M).
- Over the past year, TMO is up 14.9% and XONE is down 0.3% - TMO leads by 15.2 points.
- TMO has hit the wire 17 times in the past 4 weeks while XONE has been quiet.
- TMO has more recent analyst coverage (25 ratings vs 4 for XONE).
- Company
- Thermo Fisher Scientific Inc
- The ExOne Company
- Price
- $469.56-0.67%
- $49.28+0.02%
- Market cap
- $174.52B
- $597.0M
- 1M return
- -1.03%
- -0.19%
- 1Y return
- +14.92%
- -0.30%
- Industry
- Industrial Machinery/Components
- Industrial Machinery/Components
- Exchange
- NYSE
- NASDAQ
- IPO
- 2013
- News (4w)
- 17
- 0
- Recent ratings
- 25
- 4
Thermo Fisher Scientific Inc
Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets. Its Analytical Instruments segment provides instruments, consumables, software, and services for use in laboratory, on production line, and in field for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The company's Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, and calibration verification fluids; ImmunoCAP for allergy and asthma tests, and EliA for autoimmunity tests; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; human leukocyte antigen typing and testing for organ transplant market; and healthcare products. Its Laboratory Products and Services segment provides laboratory refrigerators and freezers, ultralow-temperature freezers, and cryopreservation storage tanks; temperature control, sample preparation and preservation, centrifugation, and biological safety cabinet products; water analysis instruments; laboratory plastics products; laboratory chemicals; and pharma services. The company offers products and services through a direct sales force, customer-service professionals, electronic commerce, third-party distributors, and catalogs. It has a strategic alliance with the University of California, San Francisco. The company was incorporated in 1956 and is based in Waltham, Massachusetts.
The ExOne Company
The ExOne Company develops, manufactures, and markets three-dimensional (3D) printing machines, 3D printed and other products, materials, and services to industrial customers in the United States, Germany, and Japan. The company manufactures and sells 3D printing machines that serves direct and indirect applications, including components and tools to produce a component; and offers pre-production collaboration and print products for customers. It also supplies associated materials comprising consumables and replacement parts; and other services, such as training and technical support services. The company markets its products under the ExOne brand name. The company was founded in 2005 and is headquartered in North Huntingdon, Pennsylvania.
Latest TMO
- Thermo Fisher downgraded by HSBC Securities with a new price target
- Wolfe Research resumed coverage on Thermo Fisher with a new price target
- SEC Form SD filed by Thermo Fisher Scientific Inc
- Thermo Fisher Scientific Unveils Next-generation Innovations at ASMS 2026 to Accelerate the Path from Drug Discovery to New Therapies
- Thermo Fisher Scientific Inc filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders
- Director Weisler Dion J covered exercise/tax liability with 80 shares and was granted 499 shares, increasing direct ownership by 8% to 5,446 units (SEC Form 4)
- Director Sperling Scott M was granted 499 shares, increasing direct ownership by 0.72% to 69,479 units (SEC Form 4)
- Director Spar Debora L was granted 499 shares, increasing direct ownership by 24% to 2,610 units (SEC Form 4)
- Director Lynch Karen S was granted 499 shares, increasing direct ownership by 76% to 1,159 units (SEC Form 4)
- Director Keith R. Alexandra was granted 499 shares, increasing direct ownership by 24% to 2,602 units (SEC Form 4)
Latest XONE
- QXO Proposes Full Slate of Independent Directors for Election at Beacon Roofing Supply's 2025 Annual Meeting
- How To Earn $500 Monthly Income With These Cash-Like Treasury ETFs
- ETF Winners And Losers: Small-Cap Fund Flows - Banking ETF Gains Over $400 Million While QQQE Loses Over $350 Million
- SEC Form EFFECT filed by The ExOne Company
- SEC Form EFFECT filed by The ExOne Company
- SEC Form 15-12B filed by The ExOne Company
- SEC Form SC 13D/A filed by The ExOne Company (Amendment)
- SEC Form 4: Zemba Douglas D. returned 48,637 shares to the company, covered exercise/tax liability with 13,067 shares and was granted 3,511 shares, closing all direct ownership in the company (for withholding tax)
- SEC Form 4: Benec Loretta Lobes returned 16,307 shares to the company, covered exercise/tax liability with 6,962 shares and was granted 3,370 shares, closing all direct ownership in the company (for tax liability)
- SEC Form 4: Lucas Rick returned 13,481 shares to the company, covered exercise/tax liability with 6,698 shares and was granted 3,441 shares, closing all direct ownership in the company to satisfy tax liability